Skip to main content
Fig. 3 | Cardiovascular Diabetology

Fig. 3

From: FSTL3 partially mediates the association of increased nonalcoholic fatty liver disease fibrosis risk with acute myocardial infarction in patients with type 2 diabetes mellitus

Fig. 3

Serum FSTL3 was significantly increased in high NAFLD fibrosis risk and AMI patients, and closely associated with NAFLD fibrosis and AMI severity in patients with T2DM and co-existent NAFLD. A: Serum FSTL3 level in AMI patients with co-existent T2DM and NAFLD patients was significantly higher than in those without AMI. B–C: Serum FSTL3 level was much higher in NAFLD fibrosis high risk than those with NAFLD fibrosis low and intermediate risk, both by NFS and FIB-4. D–F: Serum FSTL3 was closely associated with NAFLD fibrosis and AMI severity in patients with T2DM and NAFLD

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840